Page last updated: 2024-10-29

isocarboxazid and Phobic Disorders

isocarboxazid has been researched along with Phobic Disorders in 3 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.

Research Excerpts

ExcerptRelevanceReference
"Isocarboxazid was replaced by placebo, using double-blind procedure."2.67Efficacy of combined antidepressant therapy in resistant neurotic disorder. ( Murphy, S; Tyrer, P, 1990)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lawless, T1
Tyrer, P1
Murphy, S1
West, ED1

Trials

1 trial available for isocarboxazid and Phobic Disorders

ArticleYear
Efficacy of combined antidepressant therapy in resistant neurotic disorder.
    The British journal of psychiatry : the journal of mental science, 1990, Volume: 156

    Topics: Adult; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Diazepam; Do

1990

Other Studies

2 other studies available for isocarboxazid and Phobic Disorders

ArticleYear
Nursing care study: fighting phobias with drugs.
    Nursing mirror, 1982, Aug-25, Volume: 155, Issue:8

    Topics: Adult; Amobarbital; Humans; Isocarboxazid; Lorazepam; Male; Phobic Disorders

1982
Systematic desensitisation for phobias.
    Lancet (London, England), 1967, Apr-22, Volume: 1, Issue:7495

    Topics: Adult; Anxiety; Desensitization, Immunologic; Female; Humans; Isocarboxazid; Middle Aged; Phobic Dis

1967